ImportantGeneral Updates

Remus Pharmaceuticals has announced a board meeting to discuss material events and disclosures.

Remus Pharmaceuticals Limited logo
Remus Pharmaceuticals LimitedREMUS · Filed with the exchange

Key managerial personnel, including the MD, WTD, and CFO, have been designated to assess the significance of events and oversee communication.

The Company Secretary will manage stock exchange filings.

No operational or financial impact was indicated.

Read the original filing(PDF)

No comments yet. Be the first.

More from Remus Pharmaceuticals Limited

All announcements